Toys“R”Us ANZ Limited (ASX:TOY) Announces CEO Resignation
Toys“R”Us ANZ Limited (ASX:TOY) announces CEO resignation and interim leadership appointments.
Tag: Corporate Strategy & Guidance
Temple & Webster Group Limited (ASX:TPW) Announces Strong H1 FY25 Financial Results
Temple & Webster Group Limited (ASX:TPW) reports a 24% revenue increase in H1 FY25, showcasing strong financial growth and market share expansion.
Domain Holdings Australia Limited (ASX:DHG) Appoints Greg Ellis as Interim CEO
Domain Holdings Australia Limited (ASX:DHG) appoints Greg Ellis as Interim CEO, ensuring continued leadership during the search for a permanent CEO.
Domain Holdings Australia Limited (ASX:DHG) Announces 2025 Half-Year Results
Domain Holdings Australia Limited (ASX:DHG) reports a 7.4% revenue increase in FY25 H1 and declares a 2.0¢ fully franked dividend.
IAG (ASX:IAG) Announces 1H25 Financial Results and Dividend Increase
IAG (ASX:IAG) reports a net profit of $778m for 1H25 and announces a 20% increase in its interim dividend.
Praemium Limited (ASX:PPS) Announces Update on OneVue Earn Out
Praemium Limited (ASX:PPS) announces a nil earn out for the first period of its OneVue acquisition, maintaining earnings and synergy expectations.
Centuria Capital Group (ASX:CNI) Announces Creation of AI Factory & AI Marketplace
Centuria Capital Group (ASX:CNI) unveils Australia’s first public AI Factory and Marketplace, enhancing AI access for businesses and government.
Nuchev Limited (ASX:NUC) Appoints Nathan Cheong as CEO
Nuchev Limited (ASX:NUC) appoints Nathan Cheong as CEO, while Mick Myers transitions to COO and CFO roles.
Cycliq Group Limited (ASX:CYQ) Announces Half-Year Financial Results
Cycliq Group Limited (ASX:CYQ) reports an 18% revenue increase for the half-year ended December 2024, driven by strategic partnerships and enhanced marketing efforts.
Artrya Limited (ASX:AYA) Secures Multi-Year Contract with Sonic Healthcare Australia
Artrya Limited (ASX:AYA) secures a three-year agreement with Sonic Healthcare Australia to implement its Salix® platform for coronary artery disease assessment.